Berkshire Returns to Net Buying After 14 Quarters — and a Boardroom Gift Is Not a Sell Signal
Published on 10/25/2026 at 02:50 | Editorial boerse-global.de
Berkshire Hathaway's stock drew fresh attention on Wednesday as a perceived counterweight to AI chip names, with chip stocks giving ground as Buffett's conglomerate firmed. Yet two developments this week — a resumed appetite for equities and a routine insider filing — are being read by some investors as pointing in opposite directions. They do not.
The distinction matters. Ajit Jain, Berkshire's vice chairman, reported a charitable donation of 19 Class B shares on Wednesday. The mandatory disclosure to the SEC documents a gift to a nonprofit cause, not a sale on the open market. Anyone treating the filing as an insider sell-off is assigning it a meaning the document does not carry — and drawing from it a view on the share price that Jain never expressed.
Buybacks, not a blanket retreat from technology
Far more telling for valuation purposes is how Berkshire is deploying capital. Wednesday's reporting pointed to roughly $4.5 billion in share repurchases and a return to net stock purchases, ending a run of 14 consecutive quarters in which the company was a net seller of equities. Media accounts linked the recent rally to the resumption of buybacks under Greg Abel and to multibillion-dollar transactions, while investors rotated out of AI chipmakers. One report read the move as a sign that the market is increasingly putting Warren Buffett's departure behind it.
That framing captures sentiment rather than a proven single driver. Buybacks and stake purchases, by contrast, bear directly on capital allocation — which is precisely where they diverge from Jain's private gift.
Should investors sell immediately? Or is it worth buying Berkshire Hathaway?
A $330 million top-up with a stated purpose
Berkshire's own investment activity cuts against any notion that it is turning its back on technology. On October 14 the company put a further $330 million into Bending Spoons, lifting its stake in the Italian technology firm to 4%. According to Bending Spoons, the increase followed Berkshire's investment at the company's July IPO. Reuters reported the transaction was structured as a private placement of 10 million shares at $33 apiece. Bending Spoons said the financing is intended to support its acquisition strategy — a concrete use of proceeds behind the capital injection.
Holding a stake in a technology company is not the same as buying chip stocks, and the two should not be conflated. The safe-haven label attached to Berkshire in recent days describes a market reaction, not a guarantee against losses.
UBS lifts its target
Analyst support arrived on Thursday, when UBS's Brian Meredith raised his price target on Berkshire's Class B shares to $628 from $604 while keeping his buy rating. The higher target reinforces the positive mood but does not by itself justify expectations of reliable downside protection.
For investors, the takeaway sits in the combination: Berkshire was preferred over weaker chip names, returned to net equity purchases, and expanded a technology holding — all while a boardroom share transfer carried no market signal at all. Reading the stock purely as a hedge against the AI boom misses the fuller picture of deliberate capital decisions.
Ad
Berkshire Hathaway Stock: New Analysis - 25 October
Fresh Berkshire Hathaway information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
